Motaghi, Ehsan <br/><br/>
Etrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: A systematic review and indirect comparison.  [electronic resource] 

 -  Pharmacological research  01 2019 
 - 120-125 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review 
<br/><br/><label>ISSN: </label>1096-1186 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2018.11.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Colitis, Ulcerative--drug therapy<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Infliximab--therapeutic use